Merck Applies for Covid Pill Approval in Japan, Nikkei Reports
03 December 2021 - 06:16PM
Dow Jones News
--Merck & Co.'s Japan unit applied for approval of its
Covid-19 pill in the country, local business daily Nikkei reported
Friday, citing unnamed sources.
--If approved by the government, Merck plans to distribute the
pill in Japan as early as later this month, the Nikkei report
said.
Full story: https://s.nikkei.com/3DjwETO (Japanese)
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
December 03, 2021 02:01 ET (07:01 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Mar 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024